2-phenyl-1,2-benzisothiazol-3-(2h)-one has been researched along with 6-fluoro-2-phenyl-1,2-benzothiazol-3-one in 1 studies
Studies (2-phenyl-1,2-benzisothiazol-3-(2h)-one) | Trials (2-phenyl-1,2-benzisothiazol-3-(2h)-one) | Recent Studies (post-2010) (2-phenyl-1,2-benzisothiazol-3-(2h)-one) | Studies (6-fluoro-2-phenyl-1,2-benzothiazol-3-one) | Trials (6-fluoro-2-phenyl-1,2-benzothiazol-3-one) | Recent Studies (post-2010) (6-fluoro-2-phenyl-1,2-benzothiazol-3-one) |
---|---|---|---|---|---|
23 | 0 | 11 | 5 | 0 | 1 |
Protein | Taxonomy | 2-phenyl-1,2-benzisothiazol-3-(2h)-one (IC50) | 6-fluoro-2-phenyl-1,2-benzothiazol-3-one (IC50) |
---|---|---|---|
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | 10.6267 | |
hexokinase | Trypanosoma brucei brucei TREU927 | 2.31 | |
caspase recruitment domain family, member 15 | Homo sapiens (human) | 5.428 | |
glucose-6-phosphate 1-dehydrogenase isoform b | Homo sapiens (human) | 11.8 | |
receptor-interacting serine/threonine-protein kinase 2 isoform 1 | Homo sapiens (human) | 5.428 | |
rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | 36.43 | |
Neutrophil elastase | Homo sapiens (human) | 2.31 | |
Mannose-6-phosphate isomerase | Homo sapiens (human) | 1.3 | |
Phosphoethanolamine/phosphocholine phosphatase | Homo sapiens (human) | 0.79 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bravo, Y; Cosford, ND; Dahl, R; Dhanya, RP; Farquharson, C; Ganji, SR; Kiffer-Moreira, T; Lee, PS; Millán, JL; Sergienko, E; Smith, LH; Teriete, P | 1 |
1 other study(ies) available for 2-phenyl-1,2-benzisothiazol-3-(2h)-one and 6-fluoro-2-phenyl-1,2-benzothiazol-3-one
Article | Year |
---|---|
Design, synthesis and evaluation of benzoisothiazolones as selective inhibitors of PHOSPHO1.
Topics: Animals; Benzamides; Benzothiazoles; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Hepatocytes; High-Throughput Screening Assays; Humans; Hydrogen-Ion Concentration; Mice; Molecular Structure; Phosphoric Monoester Hydrolases; Small Molecule Libraries; Structure-Activity Relationship | 2014 |